EP2968868A1 - Antiseptic dead-end cap - Google Patents
Antiseptic dead-end capInfo
- Publication number
- EP2968868A1 EP2968868A1 EP14776447.6A EP14776447A EP2968868A1 EP 2968868 A1 EP2968868 A1 EP 2968868A1 EP 14776447 A EP14776447 A EP 14776447A EP 2968868 A1 EP2968868 A1 EP 2968868A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- antiseptic
- cap
- annular wall
- end cap
- dead
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000002421 anti-septic effect Effects 0.000 title claims abstract description 263
- 239000000463 material Substances 0.000 claims abstract description 74
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 229910052751 metal Inorganic materials 0.000 claims description 8
- 239000002184 metal Substances 0.000 claims description 8
- 229910052709 silver Inorganic materials 0.000 claims description 6
- 239000004332 silver Substances 0.000 claims description 6
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 4
- 229960003260 chlorhexidine Drugs 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- 239000012530 fluid Substances 0.000 description 60
- 230000007246 mechanism Effects 0.000 description 15
- 230000002209 hydrophobic effect Effects 0.000 description 10
- 239000004033 plastic Substances 0.000 description 10
- 229920003023 plastic Polymers 0.000 description 10
- 230000000845 anti-microbial effect Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- 230000002745 absorbent Effects 0.000 description 6
- 239000002250 absorbent Substances 0.000 description 6
- 238000007789 sealing Methods 0.000 description 6
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 239000003146 anticoagulant agent Substances 0.000 description 5
- 229940127219 anticoagulant drug Drugs 0.000 description 5
- 239000004599 antimicrobial Substances 0.000 description 5
- 150000002736 metal compounds Chemical class 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 229960002152 chlorhexidine acetate Drugs 0.000 description 3
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 3
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 3
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229920003031 santoprene Polymers 0.000 description 3
- 229910001923 silver oxide Inorganic materials 0.000 description 3
- 229920002725 thermoplastic elastomer Polymers 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229960002163 hydrogen peroxide Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 2
- 229940071536 silver acetate Drugs 0.000 description 2
- 229940100890 silver compound Drugs 0.000 description 2
- 150000003379 silver compounds Chemical class 0.000 description 2
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 2
- 229910000367 silver sulfate Inorganic materials 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229920001875 Ebonite Polymers 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229910021612 Silver iodide Inorganic materials 0.000 description 1
- KZNMRPQBBZBTSW-UHFFFAOYSA-N [Au]=O Chemical compound [Au]=O KZNMRPQBBZBTSW-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229940045985 antineoplastic platinum compound Drugs 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000006263 elastomeric foam Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229910001922 gold oxide Inorganic materials 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 150000003058 platinum compounds Chemical class 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229940071575 silver citrate Drugs 0.000 description 1
- 229940045105 silver iodide Drugs 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- CLDWGXZGFUNWKB-UHFFFAOYSA-M silver;benzoate Chemical compound [Ag+].[O-]C(=O)C1=CC=CC=C1 CLDWGXZGFUNWKB-UHFFFAOYSA-M 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- QUTYHQJYVDNJJA-UHFFFAOYSA-K trisilver;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Ag+].[Ag+].[Ag+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QUTYHQJYVDNJJA-UHFFFAOYSA-K 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M39/16—Tube connectors; Tube couplings having provision for disinfection or sterilisation
- A61M39/162—Tube connectors; Tube couplings having provision for disinfection or sterilisation with antiseptic agent incorporated within the connector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/20—Closure caps or plugs for connectors or open ends of tubes
Definitions
- the present invention relates to an antiseptic cap, and more particularly, to an antiseptic dead-end cap for a medical connector.
- Catheters are widely used to treat patients requiring a variety of medical procedures. Catheters can either be acute, or temporary, for short-term use or chronic for long-term treatment. Catheters are commonly introduced into central veins (such as the vena cava) from peripheral vein sites to provide access to a patient's vascular system.
- central veins such as the vena cava
- a luer connector e.g., a male luer connector
- a fluid line that is connected to a fluid source, such as an IV bag filled with fluid.
- the second end of the male luer connector can be removably attached to a first end of a female needleless luer connector.
- the second end of the female needleless luer connector can be attached to a catheter that has been introduced into a patient.
- the present invention relates to an antiseptic dead-end cap for use with a connector that includes a base having first and second sides, a first annular wall extending from the first side of the base, a cylindrical center plug extending from the first side of the base, and a second annular wall extending from the second side of the base.
- the first annular wall has an outer surface and an inner surface.
- the cylindrical center plug has an outer surface and an inner surface, and is positioned within the first annular wall to form an annular chamber.
- the second annular wall has an outer surface and an inner surface, and defines a second chamber having an open end.
- An antiseptic material is on at least one of the inner surface of the first annular wall, the inner surface of the second annular wall, the outer surface of the second annular wall, and the outer surface of the cylindrical center plug.
- the present invention further relates to an antiseptic dead-end cap for use with a connector that includes a base having first and second sides, a male connector portion extending from the first side of the base and configured to be connectable to a female luer, and a female connector portion extending from the second side of the base and configured to be connectable to a male luer.
- An antiseptic material is on at least a portion of the male luer connector portion or the female luer connector portion.
- the male connector portion includes a first annular wall extending from the first side of the base and having an outer surface and an inner surface, and a cylindrical center plug extending from the first side of the base.
- the cylindrical center plug has an outer surface and an inner surface, and is positioned within the first annular wall to form an annular chamber.
- the female connector portion includes a second annular wall extending from the second side of the base, has an outer surface and an inner surface, and defines a second chamber having an open end.
- the antiseptic material is a metal, while in other aspects, the antiseptic material can be an alcohol.
- the first annular wall includes one or more threads.
- the second annular wall includes one or more threads.
- the antiseptic material is formed in at least one of the inner surface of the first annular wall, the inner surface of the second annular wall, the outer surface of the second annular wall, and the outer surface of the cylindrical center plug.
- FIG. 1 is a cross-sectional view of an antiseptic cap assembly engaged to a luer connector according to the present invention
- FIG. 2 is a perspective view of a sealed antiseptic cap assembly
- FIG. 3 is an exploded perspective view showing the antiseptic cap assembly of FIG. 1 and a luer connector;
- FIG. 4 is a perspective view of the antiseptic cap assembly of FIG. 1 engaged to a luer connector;
- FIG. 5 is a cross-sectional view showing an antiseptic cap assembly, wherein a cap has an outer wall
- FIG. 6 is a cross-sectional view showing an antiseptic cap assembly, wherein the cap includes a center insert;
- FIG. 7 is a cross-sectional view showing an antiseptic cap assembly, wherein the cap includes a center plug;
- FIG. 8 is a cross-sectional view showing an antiseptic cap assembly, wherein a cap holder includes an inner-facing flange;
- FIG. 9 is a cross-sectional view showing an antiseptic cap assembly, wherein a center plug is provided and the cap holder includes an inner-facing flange;
- FIG. 10 is a cross-sectional view showing an antiseptic cap assembly, wherein a cap includes an annular portion without threads;
- FIG. 11 is a cross-sectional view showing an antiseptic cap assembly that includes an antiseptic chamber
- FIG. 12 is a perspective view of the antiseptic cap assembly shown in FIG.
- FIG. 13 is a perspective view showing an antiseptic cap assembly, wherein a cap holder includes retainers;
- FIG. 14 is a cross-sectional view, taken along section lines 14-14 and looking in the direction of the arrows, of the antiseptic cap assembly shown in FIG. 13;
- FIG. 15 is a cross-sectional view, taken along section lines 15-1 5, of the antiseptic cap assembly shown in FIG. 13;
- FIG. 16 is a cross-sectional view showing an antiseptic cap assembly that includes a ratchet assembly
- FIG. 17 is an exploded view of the antiseptic cap assembly shown in FIG. 16 and a luer connector;
- FIG. 18 is a partially cut away perspective view of the antiseptic cap assembly shown in FIG. 16 showing the ratchet assembly;
- FIG. 19 is a perspective view showing an antiseptic cap assembly without a cap holder
- FIG. 20 is a cross-sectional view showing the antiseptic cap assembly of FIG. 19 having hydrophobic and hydrophilic sections;
- FIG. 21 is a perspective view showing an antiseptic cap assembly, wherein a cap holder has a flange with a recess for receiving a line;
- FIG. 22 is a cross-sectional view showing an antiseptic cap assembly, wherein a plug is supported by an arm;
- FIGS. 23-27 are perspective views showing an antiseptic cap assembly with various fastening mechanisms
- FIG. 28 is a perspective view of an antiseptic dead-end cap
- FIG. 29 is a front view of the antiseptic dead-end cap
- FIG. 30 is a side view of the antiseptic dead-end cap
- FIG. 31 is another perspective view of the antiseptic dead-end cap
- FIG. 32 is another perspective view of the antiseptic dead-end cap.
- FIG. 33 is a cross-sectional view of the antiseptic dead-end cap of FIG. 28 taken along line 33-33.
- the present invention relates to an antiseptic cap assembly that engages a male end of a luer connector. It should be understood, however, that the teachings herein can be used with other types of medical connectors.
- FIG. 1 is a cross-sectional view of an antiseptic cap assembly 10 engaged to a luer connector 12.
- a proximal end 14 of the luer connector 12 is attached to a fluid line 16 which is connected to a fluid source (not shown), such as a IV bag filled with fluid.
- the luer connector 12 includes an annular threaded portion 18 with internal threads 20 and a frustoconical male luer 22 positioned for insertion into a female luer connector (not shown).
- the male luer 22 includes a tip 26 having an opening 24 in fluid communication with the fluid line 16.
- the male luer 22 is arranged substantially concentrically within the threaded portion 18. As a result of their generally coaxial arrangement, the male luer 22 and the threaded portion 18 cooperate to form an annular space therebetween.
- the antiseptic cap assembly 10 includes a cap holder 28 and a cap 30 sized to be positioned within the cap holder 28.
- the cap 30 includes a base 32 and an annular threaded portion 34 extending from the base 32.
- the base 32 could include a substantially flat surface 36 and an outer flange 38.
- the threaded portion 34 of the cap 30 includes a rim 40 that defines an open end 42 (see FIG. 3).
- the base 32 closes the opposite end of the threaded portion 34.
- the threaded portion 34 could be formed with a tapered inner surface 46 that compliments the male luer 22 of the luer connector 12. In particular, the tapered inner surface 46 narrows from the rim 40 toward the base 32.
- the threaded portion 34 defines a chamber 48 (see FIG. 3) sized to receive the male luer 22.
- the threaded portion 34 includes external threads 50 for engaging the threads 20 of the luer connector 12.
- the external threads 50 and the threads 20 of the luer connector 12 cooperate with each other so as to allow the cap 30 to be securely threadedly connected to the luer connector 12 and also to allow relative movement between the cap 30 and the luer connector 12, as the cap 30 is rotated relative to the luer connector 12.
- the external threads 50 extend between the base 32 and the rim 40.
- the configuration of the cap 30 is shown in perspective in FIG. 3. It should be noted that this configuration is exemplary.
- the cap 30 could be configured without threads and sized to engage the luer connector 12 with a push- on friction fit, as will be described hereinafter.
- the cap 30 could be made from an absorbent material.
- the cap 30 could be made from porous plastic, for example, a medical grade sintered porous plastic material which is available from Porex Corporation, based in Fairburn, GA. Other suitable manufacturers of the porous plastic material include Filtrona, Genpore, and Thermopore. It is desirable that the material can absorb and retain a fluid such as an antiseptic fluid. It is also desirable that the material is sufficiently rigid to maintain its structure. It is also desirable that the material is compressible and that the absorbed fluid is released on compression.
- the porous plastic material could be made of any suitable polymer, such as polyethylene, polypropylene, nylon, etc.
- porous plastic material is only exemplary. It will be understood that the cap 30 could be made from any other suitable material, such as bonded fiber, cotton, silicone, urethane, polyester, cellulose, etc. The material could be natural or synthetic.
- the threaded portion 34 of the cap 30 could be coated or impregnated with an antiseptic fluid, an anticoagulant fluid, and/or an antimicrobial fluid.
- An example of a suitable antiseptic fluid is isopropyl alcohol.
- the concentration of the isopropyl alcohol could vary, and is preferably 70% v/v.
- the concentration of alcohol could be in a range from 20% to 100%. It will be understand that other materials could be used, such as other alcohols, including ethanol, propanol, and/or butanol, or iodine, hydrogen peroxide, chlorhexidine gluconate, chlorhexidine acetate, etc.
- the antiseptic, anticoagulant, and/or antimicrobial agent could be in liquid or solid form.
- the cap holder 28 includes a cylindrically shaped sidewall 52 that defines a chamber 54 sized to receive the cap 30 and accommodate the male luer 22.
- the cap holder 28 could include an outer flange 56 that protrudes radially outwardly from a distal end 58 of the sidewall 52.
- the outer flange 56 defines an open end 60.
- the cap holder 28 could include a substantially flat surface 62 that defines the opposite, closed end.
- the cap holder 28 could be made from a thermoplastic elastomer, such as the thermoplastic elastomer sold by ExxonMobil under the trademark SANTOPRENE, or any other suitable material.
- the cap holder 28 could be made from a more rigid material, such as a high-density polyethylene.
- the cap holder 28 and the cap 30 could be bonded to each other, or attached to each other by any suitable method, such as by adhesive or by molding.
- a gap 64 may exist between the flange 38 of the cap 30 and the cap holder 28, and between the threaded portion 34 of the cap 30 and the cap holder 28. Also, the cap 30 is attached to the cap holder 28 such that the cap 30 rotates conjointly with the cap holder 28.
- the cap holder 28 could be sealed with a material, such as a film 66, a foil material or lid stock material, which can be attached to the flange 56 by any suitable method such as by adhesive or by conductive or inductive heat sealing techniques.
- a pull tab 68 could be provided to facilitate removal of the film 66 to provide access to the antiseptic cap 10.
- the cap 30 may be hydrophobic.
- the hydrophobic material could serve to inhibit or minimize an antiseptic fluid, such as isopropyl alcohol, from passing through the cap 30, it may be desirable to make at least a portion of the cap 30 hydrophilic.
- the hydrophilic portion could allow the alcohol to pass therethrough, whereas the hydrophobic portion could serve to inhibit or minimize an antiseptic fluid, such as isopropyl alcohol, from passing therethrough.
- the threaded portion 34 could be treated with a hydrophilic surfactant whereas the base 32 could remain hydrophobic, so as to be resistant to an antiseptic fluid, such as alcohol.
- the hydrophobic section could also act as a plug to prevent IV fluid from leaking through the tubing to go past the cap 30.
- the antiseptic cap assembly 10 is shown attached to the luer connector 12 such that the threaded portion 34 of the cap 30 mates with the threads 20 of the luer connector 12 and the base 32 is positioned adjacent the opening 24 of the male luer 22. Also, in this position, the inner surface 46 of the threaded portion 34 is adjacent the male luer 22 and the male luer 22 compresses the cap 30 to release at least a portion of the antiseptic fluid to disinfect the luer connector 12.
- the antiseptic cap assembly 10 can be allowed to remain attached to the luer connector 12 for any suitable period of time. When the antiseptic cap assembly 10 is attached to the luer connector 12, as shown in the perspective view of FIG. 4, the luer connector 12 is exposed to the antiseptic fluid.
- the cap holder 28 could be configured to remain on the cap 30 after the antiseptic cap assembly 10 engages the luer connector 12.
- the cap holder 28 could be configured to be removably attached to the cap 30.
- the cap holder 28 could be removed from the cap 30 after the antiseptic cap assembly 10 engages the luer connector 12.
- FIG. 5 shows an antiseptic cap assembly, indicated generally as 110, that is sized to engage and disinfect the male luer 22.
- the antiseptic cap assembly 110 operates and is constructed in manners consistent with the antiseptic cap assembly 10 shown in FIGS. 1-4, unless stated otherwise.
- the antiseptic cap assembly 110 includes a cap holder 128 and a cap 130 sized to be positioned within the cap holder 128.
- Cap 130 includes an annular sidewall 111 extending from an outer flange 138 and substantially concentric with the threaded portion 134.
- the annular sidewall 111 is positioned proximate an outer surface of the cap holder 12.
- the annular sidewall 111 bears against the outer surface of the threaded portion 18 of the luer connector 12.
- the annular sidewall 111 can be made from porous plastic like the remainder of the cap 130 or any other suitable material.
- the annular sidewall 111 covers and protects the outer surface of the threaded portion 18 of the luer connector 12.
- the annular sidewall 111 may contain antiseptic fluid and release at least a portion of an antiseptic fluid.
- FIG. 6 shows an antiseptic cap assembly, indicated generally as 210, that is sized to engage and disinfect a male luer 22.
- the antiseptic cap assembly 210 operates and is constructed in manners consistent with the antiseptic cap assembly 10 shown in FIGS. 1-4, unless stated otherwise.
- the antiseptic cap assembly 210 includes a cap holder 228 and a cap 230 sized to be positioned within the cap holder 228.
- Cap 230 includes a center insert 211 that is integrally connected therewith.
- the cap 230 and the center insert 211 could be separate components.
- the center insert 211 may be made from porous plastic like the remainder of the cap 230 or any other suitable material, and may contain antiseptic fluid and release at least a portion of an antiseptic fluid.
- the center insert 211 could be treated with a hydrophilic surfactant, or otherwise made hydrophilic.
- the center insert 211 protrudes from a base 232 of the cap 230 and is positioned within a threaded portion 234 of the cap 230.
- the center insert 211 has a distal end 213 that may have angled edges 215, thereby giving the center insert 211 a generally trapezoidal shape.
- the center insert 211 could define other shapes such as conical, square, rectangle, etc.
- the center insert 211 is positioned within the opening 24 formed in the male luer 22 and allows the antiseptic fluid to enter the male luer 22 to apply the antiseptic fluid to the inner tip 26 of the male luer 22.
- FIG. 7 shows an antiseptic cap assembly, indicated generally as 310, that is sized to engage and disinfect a male luer 22.
- the antiseptic cap assembly 310 operates and is constructed in manners consistent with the antiseptic cap assembly 10 shown in FIGS. 1-3, unless stated otherwise.
- the antiseptic cap assembly 310 includes a cap holder 328 and a cap 330 sized to be positioned within the cap holder 328.
- a sealing mechanism such as a center plug 311 , is sized to extend from a base 332 of the cap 330 and is sized to be positioned within the threaded portion 334 of the cap 330.
- the cap 330 and the center plug 311 could be separate components as shown or, alternatively, the cap 330 and the center plug 311 could be integrally formed. Alternatively, the center plug 311 could be an extension of the cap holder 328 molded in.
- the center plug 311 has a distal end 313 that may have angled edges 315, thereby giving the center plug 311 a generally trapezoidal shape.
- the center plug 311 could define other shapes such as conical, square, rectangle, etc.
- the center plug 311 bears against the opening 24 formed in the male luer 22 to prevent the antiseptic fluid from entering the male luer 22.
- the center plug 311 extends a distance from the base 332 sufficient to engage the opening 24 in the male luer 22 before the threaded portion 334 of the cap 330 is compressed by the male luer 22, to seal the opening 24 in the male luer 22.
- the center plug 311 could be made of a non-porous material, such as rubber, or any other suitable material.
- the center plug 311 could be made of porous plastic and left in a hydrophobic state, i.e., not treated with a surfactant like the threaded portion 334 of the cap 330, thereby inhibiting or minimizing antiseptic fluid from passing therethrough and into the opening 24 formed in the male luer 22.
- the center plug 311 serves to limit or prevent alcohol from entering the fluid line 316 of the luer connector 312.
- the center plug 311 could act as a plug to prevent IV fluid from dripping out of the line.
- sealing mechanism is only exemplary. It will be understood that the present invention could employ other sealing mechanisms.
- the sealing mechanism could be a center pin (not shown) sized to extend further into the opening 24 formed in the male luer 22 than the center plug 311. The center plug 311 may extend past the threads on the threaded portion 324 and inserted prior to thread engagement.
- FIG. 8 shows an antiseptic cap assembly, indicated generally as 410, that is sized to engage and disinfect a male luer 22.
- the antiseptic cap assembly 410 operates and is constructed in manners consistent with the antiseptic cap assembly 10 shown in FIGS. 1-4, unless stated otherwise.
- the antiseptic cap assembly 410 includes a cap holder 428 and a cap 430 sized to be positioned within the cap holder 428.
- the cap holder 428 includes an inner-facing flange 411 that may form a protective seal that closes off the interior of the cap holder 428 when the antiseptic cap assembly 410 is engaged to the luer connector 12.
- the inner flange 411 extends radially inward from a distal end 458 of the sidewall 452 of the cap holder 428.
- the inner-facing flange 411 of the cap holder 428 may contact the threaded portion 18 of the luer connector 12 to seal the interior of the cap holder 428.
- the inner-facing flange 411 of the cap holder 428 may provide a physical barrier to the ingress of pathogens, dust or other contaminants into the cap holder 428.
- the inner-facing flange 411 may serve to retain at least a portion of the antiseptic fluid from the antiseptic cap assembly 410 from leaking out.
- the inner- facing flange 411 may prevent evaporation of at least a portion of the antiseptic fluid that is retained.
- the configuration of the cap holder 428 could vary.
- the cap holder 428 could include an outer flange (not shown), such as the outer flange 56 (FIG. 1 ) that protrudes radially outwardly from the distal end 458 of the sidewall 452, as well as the inner-facing flange 411 that protrudes radially inward from the distal end 458 of the sidewall 452.
- FIG. 9 shows an antiseptic cap assembly, indicated generally as 510, that is sized to engage and disinfect a male luer 22.
- the antiseptic cap assembly 510 operates and is constructed in manners consistent with the antiseptic cap assembly 10 shown in FIGS. 1-4, unless stated otherwise.
- the antiseptic cap assembly 510 includes a cap holder 528 and a cap 530 sized to be positioned within the cap holder 528.
- the antiseptic cap assembly 510 includes a center plug 511 , such as the center plug 311 shown in FIG. 7.
- the cap holder includes an inner- facing flange 513, such as the flange 411 shown in FIG. 8.
- FIG. 10 shows an antiseptic cap assembly, indicated generally as 610, that is sized to engage and disinfect a male luer 22.
- the antiseptic cap assembly 610 operates and is constructed in manners consistent with the antiseptic cap assembly 10 shown in FIGS. 1-4, unless stated otherwise.
- the antiseptic cap assembly 610 includes a cap holder 628 and a cap 630 sized to be positioned within the cap holder 628.
- the cap 630 includes an annular portion 611 extending from a base 632.
- the annular portion 611 is configured without threads but is sized to engage the luer connector 12 with a push-on friction fit.
- the antiseptic cap assembly 610 could be removed by pulling out of the luer connector 12.
- the annular portion 611 of the cap 630 could be configured such that the inner surface contacts the male luer 22 and is compressed by the male luer 22 to release antiseptic fluid when the cap 630 is pushed on to the male luer 22.
- the outer surface of the annular portion 611 could also contact against the inner threads 18 of the threaded portion 18 of the male luer 22 and could also release antiseptic fluid on this side.
- the annular portion 611 could be configured to avoid contact with the threads 20 of the luer connector 12.
- the annular portion 611 does not need to be tapered as shown.
- FIGS. 11 and 12 show an antiseptic cap assembly, indicated generally as 710, that is sized to engage and disinfect a male luer 22.
- the antiseptic cap assembly 710 operates and is constructed in manners consistent with the antiseptic cap assembly 10 shown in FIGS. 1-3, unless stated otherwise.
- the antiseptic cap assembly 710 includes an antiseptic chamber 715 and a cap 730.
- the cap 730 includes an annular portion 711 extending from a base 732.
- the annular portion 711 is configured and sized to engage the luer connector 12 with a push-on friction fit.
- the antiseptic chamber 715 is attached to the base 732 of the cap 730 and is formed by a continuous sidewall 713 and an end wall 723.
- the sidewall 713 includes an inner flange 717 that extends radially inward from the sidewall 713.
- the flange 717 defines an open end 721 .
- the base 732 of the cap 730 is keyed to the antiseptic chamber 715.
- the base 732 of the cap 730 is positioned within the antiseptic chamber 715 such that the outer flange 738 of the base 732 is captured in the antiseptic chamber 715 by the inner flange 717 of the antiseptic chamber 715 which extends over the base 732.
- the base 732 closes off the disinfectant chamber 715 and the annular portion 711 of the cap 730 is in contact with the inner flange 717 of the antiseptic chamber 715.
- the cap 730 could be attached to the antiseptic chamber 715 such that the cap 730 rotates conjointly with the antiseptic chamber 715.
- the base 732 of the cap 730 does not need to be keyed to the antiseptic chamber 715 in a push-on design.
- the antiseptic chamber 715 can include an absorbent material 725, such as a pad, sponge, or elastomeric foam, configured to retain an antiseptic fluid.
- the absorbent material 725 could be wetted or soaked with the antiseptic fluid.
- the absorbent material 725 could be deformable.
- the cap 730 could be made from a porous plastic material that serves as a carrier for the transfer of antiseptic fluid from the disinfectant chamber 715. When the cap holder 728 is compressed, the absorbent material 725 releases at least a portion of the antiseptic fluid. The fluid can then flow through the base 732 and along the annular portion 711 to be delivered to the male luer 22.
- FIG. 12 shows a perspective view of the antiseptic cap assembly 710.
- FIGS. 13-15 show an antiseptic cap assembly, indicated generally as 810, that is sized to engage and disinfect a male luer 22.
- the antiseptic cap assembly 810 operates and is constructed in manners consistent with the antiseptic cap assembly 10 shown in FIGS. 1-3, unless stated otherwise.
- the antiseptic cap assembly 810 includes a cap holder 828 and a cap 830 sized to be positioned within the cap holder 828.
- the cap 830 includes an annular portion 811 extending from a base 832.
- the annular portion 811 is configured without threads and sized to engage the luer connector 12 with a push-on friction fit.
- the antiseptic cap assembly 810 could be removed by pulling out of the luer connector 12.
- the cap holder 828 includes retainers 813 that serve to retain or secure the cap 830 on the luer connector 12.
- the retainers 813 include a pair of shoulders 815, 817 that extend perpendicularly from opposite sides of the outer flange 856 of the cap holder 828 and a pair of arms 823, 825 that extend radially inward from the shoulders 815, 817.
- the retainers 813 could be made from a thermoplastic elastomer, such as SANTOPRENE, or any other suitable material.
- the retainers 813 could be made from a flexible material.
- the cap holder 828 may include gripping areas defined by a recessed portion 827 (FIGS. 13 and 15) and a recessed portion 829 (FIGS. 13 and 15) on opposite sides of the outer sidewall 852.
- the recessed portions 827, 829 are configured for gripping the cap 830 to attach the cap 830 to the male luer 22.
- FIGS. 16-18 show an antiseptic cap assembly, indicated generally as 910, that is sized to engage and disinfect a male luer 22.
- the antiseptic cap assembly 910 operates and is constructed in manners consistent with the antiseptic cap assembly 10 shown in FIGS. 1-4, unless stated otherwise.
- the antiseptic cap assembly 910 includes a cap holder 928 and a cap 930 inserted within the cap holder 928. This embodiment includes a mechanism to prevent overtightening of the cap 930 on the male luer 22 which could damage the male luer 22. This is addressed with a ratchet assembly.
- the cap 930 includes a base 932 and an annular threaded portion 934 extending from the base 932.
- the base 932 includes an outer flange 938 with a plurality of teeth 911 (see FIGS. 17 and 18), along the outer perimeter that allows for rotation in only one direction. Alternatively, it could be configured to allow for rotation in both directions by angling both surfaces of the teeth.
- the teeth 911 have angled faces 912 and generally perpendicular faces 914.
- the cap holder 928 includes a retaining mechanism for retaining the cap 930 in the cap holder 928.
- the retaining mechanism could include a first protrusion 913 that extends from one section of the sidewall 952 of the cap holder 928, and a second protrusion 915 that extends from an opposite section of the sidewall 952 of the cap holder 928.
- the first and second protrusions 913, 915 are configured to extend over the base 932 of the cap 930.
- the retaining mechanism could include a single ring around the interior of the cap holder 928.
- the cap holder 928 includes a plurality of teeth 917 that mate with the teeth 911 to form a ratchet mechanism.
- the teeth 917 interact with the teeth 911 to allow the cap 930 to rotate in the cap holder 928 in only one direction, and have angled faces 916 and generally perpendicular faces 918, like the teeth 911 of the base 932. Alternatively, it could be configured to allow for rotation in both directions.
- the ratchet mechanism provides an audible or a tactile feedback to indicate that the antiseptic cap assembly 910 is properly secured. Also, the ratchet mechanism could limit torque to prevent damage to the luer connector 12 or to the cap 930.
- the cap 930 is threaded on the male luer 22 in accordance with other embodiments of the cap 930. If the cap 930 is turned beyond the limit of the threads, instead of damaging the male luer 22, the cap 930 will slide with respect to the cap holder 928, the angled teeth 911 , 917 of the base 932 of the cap 930 and the cap holder 930 respectively sliding past one another to prevent further tightening of the cap 930 onto the male luer 22. When removing the cap 930 from the male luer 22, the generally perpendicular faces 914, 918 engage and do not permit sliding.
- FIG. 19 shows an antiseptic cap assembly, indicated generally as 1010, that is sized to engage and disinfect a male luer 22.
- the antiseptic cap assembly 1010 operates and is constructed in manners consistent with the antiseptic cap assembly 10 shown in FIGS. 1-4, unless stated otherwise.
- the cap 1030 is used without a cap holder.
- the cap 1030 includes a base 1032 and an annular threaded portion 1034 extending from the base 1032.
- Antiseptic fluid can be associated with the interior surface of the annular threaded portion 1034.
- the configuration of the cap 1030 is only exemplary.
- the cap 1030 could be configured without threads and sized to engage the luer connector 12 with a push-on friction fit.
- the cap 1030 could also include a sidewall, like that shown in FIG. 5.
- FIG. 20 shows an antiseptic cap assembly, indicated generally as 1110, that is sized to engage and disinfect a male luer.
- the antiseptic cap assembly 1110 operates and is constructed in manners consistent with the antiseptic cap assembly 1010 shown in FIG. 18, unless stated otherwise.
- At least a portion of the cap 1130 could be treated with a hydrophilic surfactant, or otherwise made hydrophilic.
- the threaded portion 1134 could be treated with a hydrophilic surfactant whereas the base 1132 could remain hydrophobic, so as to be resistant to and non-absorbent of an antiseptic fluid.
- a center plug 1111 could bear against the opening 24 formed in the male luer 22 to prevent the antiseptic fluid from entering the male luer 22.
- the center plug 1111 could be made of porous plastic and left in a hydrophobic state, thereby inhibiting or minimizing antiseptic fluid from passing therethrough and into the opening 24 formed in the male luer 22.
- the hydrophobic section could also act as a plug in the IV line to prevent ingress of antiseptic fluid or to stop leakage of IV fluid.
- FIG. 21 shows an antiseptic cap assembly, indicated generally as 1210, that is sized to engage and disinfect a male luer 22.
- the antiseptic cap assembly 1210 operates and is constructed in manners consistent with the antiseptic cap assembly 10 shown in FIGS. 1-4, unless stated otherwise.
- the cap holder 1228 has a notch 1211 in an outer flange 1256 that is configured to attached to a supporting surface, such as a fluid line 1213.
- the cap holder 1228 has a plurality of ribs 1215 extending along a sidewall 1252 from one end 1217 of the cap holder 1228 to the opposite end 1219 of the cap holder 1228.
- the ribs 1215 facilitate gripping of the cap holder 1228.
- FIG. 22 shows an antiseptic cap assembly, indicated generally as 1310, that is sized to engage and disinfect a male luer.
- the antiseptic cap assembly 1310 operates and is constructed in manners consistent with the antiseptic cap assembly 10 shown in FIGS. 1-3, unless stated otherwise.
- the antiseptic cap assembly 1310 includes a cap holder 1328 and a cap 1330 sized to be positioned within the cap holder 1328.
- a sealing mechanism such as a center plug 1311
- the center plug 1311 is sized to extend from the cap holder 1328 through the base 1332 and is sized to be positioned within the threaded portion 1334 of the cap 1330.
- the center plug 1311 is made of a non-porous material such as SANTOPRENE, or any other suitable material.
- the center plug 1311 includes an arm 1313 with one end 1315 extending from the base 1332, and a sphere 1317 attached to an opposite end 1319 of the arm 1313.
- the sphere 1317 is configured to bear against the opening 24 formed in the male luer 22 to limit the distance that the antiseptic fluid can travel into the male luer 22.
- the center plug 1311 could extend from the base 1332 and be made of another material such as rubber.
- the sphere 1317 could be replaced with a non-spherical device.
- any of the antiseptic cap assemblies 10, 110, 210, 310, 410, 510, 610, 710, 810, 910, 1010, 1110, 1210, and 1310 disclosed herein could be configured to be removably attached to a suitable surface (not shown), such as a IV bag, IV pump, or IV pole, etc., for use.
- a suitable surface such as a IV bag, IV pump, or IV pole, etc.
- the substantially flat surface 62 of the cap holder 28 includes a clip 80 sized to removeably secure the antiseptic cap assembly 10 to a supporting surface (not shown), such as a IV bag.
- a hook 82 could be provided extending from the substantially flat surface 62 of the cap holder 28 and sized to removeably secure the antiseptic cap assembly 10 to a supporting surface (not shown).
- a horseshoe-shaped clip 84 could be provided extending from the substantially flat surface 62 of the cap holder 28 and sized to releasably fasten an antiseptic cap assembly 10 to a supporting surface (not shown).
- the location of a fastening member could vary.
- the sidewall 52 of the cap holder 28 includes a clip 86.
- the end surface 62 of the cap holder 28 includes an adhesive 88 that could be covered by a release sheet 89.
- the adhesive 88 could be used to attach the antiseptic cap assembly 10 to a supporting surface, such as a IV pole.
- a pull tab 90 could be provided to remove the release sheet 89 to expose the adhesive 88.
- the antiseptic cap assembly could include a ring (not shown).
- the antiseptic cap assembly could be incorporated in kits with flush syringes, caps for treating a catheter or needleless connector, and line access devices, etc.
- the antiseptic fluid used could include an anticoagulant material, and/or an antimicrobial material. Examples of antiseptic fluid that could be used are disclosed in U.S. patent application Nos. 1 1 /821 ,190, filed on June 22, 2007, and 12/214,526, filed on June 19, 2008. The entire disclosures of U.S. patent application Nos. 1 1 /821 ,190 and 12/214,526 are incorporated herein by reference in their entirety.
- FIG. 28 is a perspective view of a multifunction antiseptic dead-end cap 1410.
- the antiseptic dead-end cap 1410 includes a first portion 1412, e.g., a male connector portion, that connects to a female luer (not shown) and a second portion 1414, e.g., a female connector portion, that connects to a male luer (not shown).
- the male luer or the female luer may, respectively, be attached to a fluid source (not shown), such as an IV bag filled with fluid.
- the male luer may be the male luer 22 illustrated in FIGS. 1 and 3-27 and described with respect thereto.
- the first portion 1412 includes a first annular wall 1416 extending from a base 1418.
- the first annular wall 1416 includes one or more threads 1420 positioned on an interior wall of the first annular wall 1416.
- the threads 1420 of the first portion 1412 are configured to engage and cooperate with threads of a female luer to allow the dead-end cap 1410 to be securely threadedly connected to the female luer.
- the first annular wall 1416 defines an open end 1422.
- the base 1418 closes the opposite end of the first annular wall 1416.
- a cylindrical center plug 1430 extends from the base 1418 in the direction of the first annular wall 1416 and is closed by an end wall 1432.
- the first annular wall 1416 and the cylindrical center plug 1430 are coaxial with one another and the cylindrical center plug 1430 is smaller in diameter than the first annular wall 1416.
- the first annular wall 1416, the base 1418, and the cylindrical center plug 1430 define a first chamber 1424 that is annular, accessible by the open end 1422, and sized to receive the female luer.
- the second portion 1414 includes a second annular wall 1426 extending from the base 1418 opposite the direction of the first annular wall 1416, and forms an internal shoulder 1428 with the base 1418.
- the second annular wall 1426 has an open end 1434 and forms a second chamber 1436, while the cylindrical center plug 1430 and the end wall 1432 form a third chamber 1438.
- the second chamber 1436 and the third chamber 1438 are in fluidic communication, and the second chamber 1436 is accessible by the open end 1434.
- the second chamber 1436 is sized to receive a male luer.
- One or more threads 1440 are positioned on an exterior wall of the second annular wall 1426.
- the threads 1440 are configured to engage and cooperate with threads of a male luer connector, such as luer connector 12 shown in FIG. 1.
- the threads 1440 and the threads of the male luer connector cooperate with each other so as to allow the dead-end cap 1410 to be securely threadedly connected to the male luer connector.
- the dead-end cap 1410 may include a plurality of external ridges 1442 provided on the first portion 1412 to facilitate gripping of the dead-end cap 1410 during handling and connecting with a connector.
- the male luer connector 12 shown in FIG. 1 as an example, when the male luer connector 12 engages the second portion 1414, the male luer 22 of the male luer connector 12 is inserted into the open end 1434 and into the second chamber 1436. As the threads 20 of the male luer connector 12 engage the threads 1440 of the second portion 1414, the male luer 22 traverses further into the second chamber 1436 and may traverse into the third chamber 1428.
- the second annular wall 1426 could be formed with a tapered shape that compliments the male luer 22 of the luer connector 12. In such a configuration, the second annular wall 1426 may narrow from the open end 1434 to the base 1418.
- the antiseptic dead-end cap 1410 has a dual operability wherein it is configured to not only attach to a male luer connector, but also a female luer connector.
- a female luer connector can include a circumferential wall that defines a chamber and has external threads.
- the circumferential wall of the female luer connector is inserted through the open end 1422 and into the first chamber 1424, such that the cylindrical center plug 1420 is inserted into the circumferential wall of the female luer connector.
- the dead-end cap 1410 can be twisted so that the one or more threads 1420 engage the female luer connector, securing the dead-end cap 1410 with the female luer connector.
- FIG. 33 is a cross-section of the multifunction antiseptic dead-end cap 1410 of FIG. 28 taken along line 33-33.
- FIG. 33 shows the configuration of the deadend cap 1410 in greater detail.
- the dead-end cap 1410 could be configured without the first portion threads 1420 and/or the second portion threads 1440.
- the first annular wall 1416 and the cylindrical center plug 1430 may be sized to engage a female luer connector with a push-on friction fit.
- the second annular wall 1426 may be sized to engage a male luer connector with a push-on friction fit.
- the dead-end cap 1410 functions to cap a male luer connector and/or a female luer connector so that fluid does not leak from a fluid source.
- the deadend cap 1410 may be used for a temporary disconnect of male and female luers so that they do not warrant disposal.
- the antiseptic cap disclosed herein includes male and female connector portions, it could also be provided having just a male or just a female portion.
- the dead-end cap 1420 could include the base 1418, the first annular wall 1416 extending from the base 1418, the cylindrical center plug 1430 extending from the base 1418 in the direction of the first annular wall 1416 and closed by the end wall 1432, and the plurality of threads 1420.
- the second annular wall 1426, and the female side of the cap can be eliminated.
- the dead-end cap 1420 could include the base 1418, the second annular wall 1426 and the threads 1440, with the base 1418 and the second annular wall 1426 defining the second chamber 1436.
- the first annular wall 1416, and the cylindrical center plug 1430 could be eliminated.
- Portions of the antiseptic dead-end cap 1410 such as an inner surface of the first annular wall 1416, the plurality of threads 1420, an outer surface of the second annular wall 1426, an inner surface of the second annular wall 1426, and the second portion threads 1440, could be coated or impregnated with an antiseptic fluid, an anticoagulant fluid, and/or an antimicrobial fluid.
- An example of a suitable antiseptic fluid is isopropyl alcohol.
- the concentration of the isopropyl alcohol could vary, and is preferably 70%.
- the concentration of alcohol could be in a range from 20% to 100%.
- antiseptic, anticoagulant, and/or antimicrobial agent could be in liquid or solid form.
- the antiseptic dead-end cap 1410 may be constructed of a material having a 40-60 durometer hardness value on a Shore A scale.
- the material may be a medium soft to medium hard rubber that is plyable and malleable for purposes of engagement with a luer.
- the devices described herein can be coated with an antiseptic coating by any suitable technique such as immersion of the part into an antiseptic solution, by spray coating the part with the antiseptic solution, by blending the antiseptic solution or material into the polymeric material used to fabricate the device.
- a quantity of physiological, antimicrobial metal compound is added to the resin for direct molding of an article.
- Physiological, antimicrobial metals are meant to include the precious metals, such as silver, gold and platinum, and copper and zinc.
- Physiological, antimicrobial metal compounds used herein include oxides and salts of preferably silver and also gold, for example: silver acetate, silver benzoate, silver carbonate, silver citrate, silver chloride, silver iodide, silver nitrate, silver oxide, silver sulfa diazine, silver sulfate, gold chloride and gold oxide.
- Platinum compounds such as chloroplatinic acid or its salts (e.g., sodium and calcium chloroplatinate) may also be used.
- compounds of copper and zinc may be used, for example: oxides and salts of copper and zinc such as those indicated above for silver.
- Single physiological, antimicrobial metal compounds or combinations of physiological, antimicrobial metal compounds may be used.
- Preferred physiological, antimicrobial metal compounds used in this invention are silver acetate, silver oxide, silver sulfate, gold chloride and a combination of silver oxide and gold chloride.
- the particles of the silver compounds are sufficiently able to be extracted to form a zone of inhibition to prevent and kill bacteria growth.
- the devices herein are impregnated with triclosan and silver compounds or triclosan and chlorhexidine, or chlorhexidine gluconate, or chlorhexidine acetate.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/803,289 US10166381B2 (en) | 2011-05-23 | 2013-03-14 | Antiseptic cap |
PCT/US2014/023140 WO2014159346A1 (en) | 2013-03-14 | 2014-03-11 | Antiseptic dead-end cap |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2968868A1 true EP2968868A1 (en) | 2016-01-20 |
EP2968868A4 EP2968868A4 (en) | 2016-08-03 |
Family
ID=51625149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14776447.6A Withdrawn EP2968868A4 (en) | 2013-03-14 | 2014-03-11 | Antiseptic dead-end cap |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2968868A4 (en) |
JP (1) | JP2016511111A (en) |
CN (1) | CN105102055A (en) |
AU (1) | AU2014240994A1 (en) |
CA (1) | CA2905829A1 (en) |
WO (1) | WO2014159346A1 (en) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11229746B2 (en) | 2006-06-22 | 2022-01-25 | Excelsior Medical Corporation | Antiseptic cap |
US9259535B2 (en) | 2006-06-22 | 2016-02-16 | Excelsior Medical Corporation | Antiseptic cap equipped syringe |
US9078992B2 (en) | 2008-10-27 | 2015-07-14 | Pursuit Vascular, Inc. | Medical device for applying antimicrobial to proximal end of catheter |
US10166381B2 (en) | 2011-05-23 | 2019-01-01 | Excelsior Medical Corporation | Antiseptic cap |
CA2841832C (en) | 2011-07-12 | 2019-06-04 | Pursuit Vascular, Inc. | Device for delivery of antimicrobial agent into a trans-dermal catheter |
US9750928B2 (en) | 2013-02-13 | 2017-09-05 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
US10376686B2 (en) | 2014-04-23 | 2019-08-13 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
AU2015252808B2 (en) | 2014-05-02 | 2019-02-21 | Excelsior Medical Corporation | Strip package for antiseptic cap |
US10232088B2 (en) | 2014-07-08 | 2019-03-19 | Becton, Dickinson And Company | Antimicrobial coating forming kink resistant feature on a vascular access device |
JP6822978B2 (en) | 2015-05-08 | 2021-01-27 | アイシーユー・メディカル・インコーポレーテッド | Medical connector configured to accept the emitter of a therapeutic agent |
WO2016198092A1 (en) | 2015-06-08 | 2016-12-15 | Stephan Fox | Apparatus for connecting a tube connector to a fitting and to fasten or unfasten closure caps |
US10493244B2 (en) | 2015-10-28 | 2019-12-03 | Becton, Dickinson And Company | Extension tubing strain relief |
US11324938B2 (en) | 2015-11-30 | 2022-05-10 | Avent, Inc. | Flexible cap for conical connectors |
JP6743379B2 (en) * | 2015-12-03 | 2020-08-19 | 株式会社ジェイ・エム・エス | Wiping tip |
SG11201805607YA (en) | 2016-01-18 | 2018-08-30 | Becton Dickinson Co | Disinfection cap for iv needleless connectors |
PL3525865T3 (en) | 2016-10-14 | 2023-02-06 | Icu Medical, Inc. | Sanitizing caps for medical connectors |
CA3047670A1 (en) * | 2016-12-24 | 2018-06-28 | Peripal Ag | Unit for a mechanical connecting device for medical purposes, particularly for peritoneal dialysis |
WO2018195241A1 (en) | 2017-04-21 | 2018-10-25 | Becton, Dickinson And Company | Connector cap |
ES2901987T3 (en) * | 2017-04-24 | 2022-03-24 | Centrotherm Systemtechnik Gmbh | Exhaust gas evacuation device with measuring point system |
WO2018204206A2 (en) | 2017-05-01 | 2018-11-08 | Icu Medical, Inc. | Medical fluid connectors and methods for providing additives in medical fluid lines |
JP6841730B2 (en) * | 2017-06-28 | 2021-03-10 | テルモ株式会社 | Holder |
KR102658959B1 (en) * | 2017-06-30 | 2024-04-22 | 리제너론 파아마슈티컬스, 인크. | Auto-injector with anti-roll feature |
WO2019092571A1 (en) * | 2017-11-09 | 2019-05-16 | 3M Innovative Properties Company | Disinfecting cap for luer devices |
JP7179760B2 (en) * | 2017-12-06 | 2022-11-29 | 住友ゴム工業株式会社 | tip cap |
US11083847B2 (en) | 2018-01-26 | 2021-08-10 | Becton, Dickinson And Company | Flush syringe with flip cap |
US11344715B2 (en) | 2018-01-26 | 2022-05-31 | Becton, Dickinson And Company | Flush syringe with disinfecting feature |
CN110090354B (en) | 2018-01-30 | 2023-01-17 | 贝克顿·迪金森公司 | Universal connector or cap for male and female threaded fittings |
WO2019178560A1 (en) * | 2018-03-16 | 2019-09-19 | Icu Medical, Inc. | Sanitizing caps for medical connectors |
CA3096333A1 (en) * | 2018-04-10 | 2019-10-17 | Becton, Dickinson And Company | Universal single-use cap for male and female connectors |
US20210138221A1 (en) * | 2018-04-10 | 2021-05-13 | Bection, Dickinson And Company | Universal Single-Use Cap For Male And Female Connectors |
US11273298B2 (en) * | 2018-04-10 | 2022-03-15 | Becton, Dickinson And Company | Universal single-use cap for male and female connectors |
MX2020011452A (en) * | 2018-05-01 | 2020-12-07 | Fresenius Medical Care Holdings Inc | Multi-purpose cap for fluid ports on a medical device. |
EP3810254B1 (en) * | 2018-06-20 | 2024-02-21 | Fresenius Kabi Deutschland GmbH | Connector assembly for connecting medical lines comprising a cap element |
MX2020014294A (en) * | 2018-06-25 | 2021-06-15 | Peripal Ag | Unit for a mechanical connecting device for medical purposes, particularly for peritoneal dialysis. |
EP3593840A1 (en) * | 2018-07-12 | 2020-01-15 | Becton Dickinson France | Glass made luer tip with marking means and method for manufacturing the same |
CN112703031B (en) | 2018-09-14 | 2022-09-13 | 贝克顿·迪金森公司 | Universal sterilizing cap |
US11534595B2 (en) | 2018-11-07 | 2022-12-27 | Icu Medical, Inc. | Device for delivering an antimicrobial composition into an infusion device |
US11541221B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Tubing set with antimicrobial properties |
US11541220B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Needleless connector with antimicrobial properties |
US11517732B2 (en) | 2018-11-07 | 2022-12-06 | Icu Medical, Inc. | Syringe with antimicrobial properties |
US11400195B2 (en) | 2018-11-07 | 2022-08-02 | Icu Medical, Inc. | Peritoneal dialysis transfer set with antimicrobial properties |
CA3118905A1 (en) | 2018-11-21 | 2020-05-28 | Icu Medical, Inc. | Antimicrobial device comprising a cap with ring and insert |
BR112021010340A2 (en) * | 2018-11-30 | 2021-08-24 | Becton, Dickinson And Company | Rotary Enabled Universal Connector Cover |
AU2019388896A1 (en) * | 2018-11-30 | 2021-07-08 | Becton, Dickinson And Company | Dual ended disinfecting cap for stopcock valves |
US11511100B2 (en) | 2019-01-30 | 2022-11-29 | Becton, Dickinson And Company | Universal cap for male and female connectors |
CA3130950A1 (en) * | 2019-02-19 | 2020-08-27 | CleanSite Medical, Inc. | Capping and cleansing devices for needlefree vascular access connectors |
US12329925B2 (en) | 2019-08-08 | 2025-06-17 | Becton, Dickinson And Company | Universal cap with pressure seal |
US11975168B2 (en) | 2019-11-18 | 2024-05-07 | Becton, Dickinson And Company | Disinfectant cap |
US11890445B2 (en) | 2019-12-23 | 2024-02-06 | Becton, Dickinson And Company | Universal disinfection cap |
US11857753B2 (en) | 2019-12-23 | 2024-01-02 | Becton, Dickinson And Company | Disinfecting syringe tip |
US12029828B2 (en) | 2020-03-05 | 2024-07-09 | Becton, Dickinson And Company | Disinfection cap |
JP7359071B2 (en) * | 2020-04-10 | 2023-10-11 | ニプロ株式会社 | Antifouling sheet for medical connectors |
US11890446B2 (en) | 2020-04-17 | 2024-02-06 | Becton, Dickinson And Company | Cap for male and female threaded fittings |
JP7070601B2 (en) * | 2020-04-17 | 2022-05-18 | 株式会社ジェイ・エム・エス | Wiping tip |
US12005223B2 (en) * | 2020-04-17 | 2024-06-11 | Becton, Dickinson And Company | Disinfection cap |
US11969572B2 (en) | 2020-04-17 | 2024-04-30 | Becton, Dickinson And Company | Disinfection cap |
WO2022125474A1 (en) | 2020-12-07 | 2022-06-16 | Icu Medical, Inc. | Peritoneal dialysis caps, systems and methods |
WO2025048845A1 (en) * | 2023-08-30 | 2025-03-06 | Becton, Dickinson And Company | Flush syringe with integrated male and female luer scrubbing devices |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3987930A (en) * | 1974-09-26 | 1976-10-26 | Ethicon, Inc. | Dual-ended tubing cap |
US4440207A (en) * | 1982-05-14 | 1984-04-03 | Baxter Travenol Laboratories, Inc. | Antibacterial protective cap for connectors |
US8167847B2 (en) * | 2006-06-22 | 2012-05-01 | Excelsior Medical Corporation | Antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly |
US8177761B2 (en) * | 2007-01-16 | 2012-05-15 | The University Of Utah Research Foundation | Assembly for cleaning luer connectors |
US8197749B2 (en) * | 2007-01-16 | 2012-06-12 | The University Of Utah Research Foundation | Methods for cleaning luer connectors |
US8336152B2 (en) * | 2007-04-02 | 2012-12-25 | C. R. Bard, Inc. | Insert for a microbial scrubbing device |
US8065773B2 (en) * | 2007-04-02 | 2011-11-29 | Bard Access Systems, Inc. | Microbial scrub brush |
US8252247B2 (en) * | 2008-05-06 | 2012-08-28 | Ferlic Michael J | Universal sterilizing tool |
CN102834140B (en) * | 2010-03-23 | 2015-11-25 | N.V.努特里西阿公司 | For the three-dimensional cut-out tap of enteral tube feed application |
JP2013523222A (en) * | 2010-03-26 | 2013-06-17 | イベラ・メディカル・コーポレイション | Medical device cleaning device with friction fit and energy director |
EP2444117A1 (en) * | 2010-10-20 | 2012-04-25 | Fresenius Kabi Deutschland GmbH | Protective cap for a connector |
US9867975B2 (en) * | 2011-05-23 | 2018-01-16 | Excelsior Medical Corporation | Antiseptic line cap |
-
2014
- 2014-03-11 EP EP14776447.6A patent/EP2968868A4/en not_active Withdrawn
- 2014-03-11 CA CA2905829A patent/CA2905829A1/en not_active Abandoned
- 2014-03-11 CN CN201480020638.XA patent/CN105102055A/en active Pending
- 2014-03-11 AU AU2014240994A patent/AU2014240994A1/en not_active Abandoned
- 2014-03-11 WO PCT/US2014/023140 patent/WO2014159346A1/en active Application Filing
- 2014-03-11 JP JP2016501159A patent/JP2016511111A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2905829A1 (en) | 2014-10-02 |
AU2014240994A1 (en) | 2015-10-08 |
WO2014159346A1 (en) | 2014-10-02 |
JP2016511111A (en) | 2016-04-14 |
EP2968868A4 (en) | 2016-08-03 |
CN105102055A (en) | 2015-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US12076521B2 (en) | Antiseptic cap | |
US9867975B2 (en) | Antiseptic line cap | |
WO2014159346A1 (en) | Antiseptic dead-end cap | |
US12296137B2 (en) | Needleless connector and access port disinfection cleaner and antimicrobial protection cap | |
US10695550B2 (en) | Caps for needleless connectors | |
EP3466481B1 (en) | Antimicrobial caps for medical connectors | |
US10029087B2 (en) | Disinfection device for connectors | |
JP2019531814A (en) | Purification cap for medical connector | |
US10576261B2 (en) | Device male port cleaner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20151002 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20160706 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61M 25/16 20060101AFI20160630BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20170202 |